WASHINGTON — For the first time, federal health officials are taking aim at telehealth companies promoting … FDA takes aim at Hims and other telehealth services in drug advertising blitzRead more
Hims
WASHINGTON — For the first time, federal health officials are taking aim at telehealth companies promoting … FDA takes aim at Hims and other telehealth services in drug advertising blitzRead more